Compound Detail
CHEMBL1684984
IZORLISIB 🧪 Phase II
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
🧪 Phase II
Basic Information
| ChEMBL ID | CHEMBL1684984 |
| Name | IZORLISIB |
| Phase | Phase II |
| Structure Type | MOL |
| InChI Key | JEGHXKRHKHPBJD-UHFFFAOYSA-N |
12
Targets
22
Activities
1
Assay Types
30
PK Parameters
20
Publications
7
Known Names
1
Indications
1
Mechanisms
Molecular Properties
377.4
MW (Da)
-0.33
ALogP
9
HBA
1
HBD
127.4
PSA (Ų)
0.76
QED
0
Ro5 Violations
3
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Chirality | Achiral |
Mechanism of Action
| Mechanism | Action Type | Target | Direct | Efficacy |
|---|---|---|---|---|
| PI3-kinase class I inhibitor | INHIBITOR | PI3-kinase class I | ✓ | ✓ |
Indications
Neoplasms
Activity Summary
IC50 22 meas. best 7.85
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform CHEMBL4005 | IC50 | 7.85 | 7.85 | 14.0 | 4 |
| NON-PROTEIN TARGET CHEMBL3879801 | IC50 | 7.5 | 7.5 | 32.0 | 2 |
| Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform CHEMBL3267 | IC50 | 7.44 | 7.44 | 36.0 | 3 |
| T47D CHEMBL614361 | IC50 | 7.25 | 7.25 | 56.0 | 1 |
| Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform CHEMBL3130 | IC50 | 6.92 | 6.5067 | 120.0 | 3 |
| Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform CHEMBL3145 | IC50 | 6.92 | 6.7133 | 120.0 | 3 |
| SK-OV-3 CHEMBL614925 | IC50 | 6.92 | 6.92 | 120.0 | 1 |
| ME-180 CHEMBL1075499 | IC50 | 6.85 | 6.85 | 140.0 | 1 |
| MFE-280 CHEMBL1075502 | IC50 | 6.75 | 6.75 | 180.0 | 1 |
| HCT-116 CHEMBL394 | IC50 | 6.7 | 6.7 | 200.0 | 1 |
| Serine/threonine-protein kinase mTOR CHEMBL2842 | IC50 | 5.8 | 5.8 | 1600.0 | 1 |
| Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit beta CHEMBL5554 | IC50 | 5.28 | 5.28 | 5300.0 | 1 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| AUC | 1930.0 | ng.hr.mL-1 | Mus musculus |
| AUC | 978.0 | ng.hr.mL-1 | Mus musculus |
| AUC | 1350.0 | ng.hr.mL-1 | Rattus norvegicus |
| AUC | 1790.0 | ng.hr.mL-1 | Rattus norvegicus |
| AUC | 660.0 | ng.hr.mL-1 | Canis lupus familiaris |
| AUC | 1430.0 | ng.hr.mL-1 | Canis lupus familiaris |
| AUC | 692.0 | ng.hr.mL-1 | Macaca mulatta |
| AUC | 2170.0 | ng.hr.mL-1 | Macaca mulatta |
| CL | 17.5 | mL.min-1.kg-1 | Mus musculus |
| CL | 6.3 | mL.min-1.kg-1 | Rattus norvegicus |
| CL | 6.4 | mL.min-1.kg-1 | Canis lupus familiaris |
| CL | 6.2 | mL.min-1.kg-1 | Macaca mulatta |
| CL | 5.37 | uL.min-1.(10^6cells)-1 | Rattus norvegicus |
| CL | 3.0 | uL.min-1.(10^6cells)-1 | Homo sapiens |
| F | 101.0 | % | Mus musculus |
| F | 101.0 | % | Mus musculus |
| F | 66.2 | % | Rattus norvegicus |
| F | 54.2 | % | Canis lupus familiaris |
| F | 78.4 | % | Macaca mulatta |
| T1/2 | 6.0 | hr | Homo sapiens |
| T1/2 | 1.7 | hr | Mus musculus |
| T1/2 | 3.8 | hr | Mus musculus |
| T1/2 | 2.6 | hr | Rattus norvegicus |
| T1/2 | 3.5 | hr | Rattus norvegicus |
| T1/2 | 1.6 | hr | Canis lupus familiaris |
| T1/2 | 3.3 | hr | Canis lupus familiaris |
| T1/2 | 3.2 | hr | Macaca mulatta |
| T1/2 | 6.7 | hr | Macaca mulatta |
| Tmax | 0.25 | hr | Mus musculus |
| Tmax | 0.8 | hr | Rattus norvegicus |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 21316229 | 10.1016/j.bmcl.2011.01.065 | Mus musculus | 8 |
| 21316229 | 10.1016/j.bmcl.2011.01.065 | Rhesus monkey | 7 |
| 21316229 | 10.1016/j.bmcl.2011.01.065 | Canis familiaris | 7 |
| 21316229 | 10.1016/j.bmcl.2011.01.065 | Rattus norvegicus | 7 |
| 21316229 | 10.1016/j.bmcl.2011.01.065 | NON-PROTEIN TARGET | 5 |
| - | 10.6019/CHEMBL4808148 | Histone deacetylase 6 | 2 |
| - | 10.6019/CHEMBL4495565 | SARS-CoV-2 | 2 |
| - | 10.6019/CHEMBL3301361 | No relevant target | 2 |
| - | 10.6019/CHEMBL3301361 | ADMET | 2 |
| 21316229 | 10.1016/j.bmcl.2011.01.065 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | 1 |
| 38157838 | 10.1016/j.bmc.2023.117561 | Unchecked | 1 |
| 21316229 | 10.1016/j.bmcl.2011.01.065 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 1 |
| 21316229 | 10.1016/j.bmcl.2011.01.065 | Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit alpha | 1 |
| 21316229 | 10.1016/j.bmcl.2011.01.065 | Phosphatidylinositol 3-kinase catalytic subunit type 3 | 1 |
| 21316229 | 10.1016/j.bmcl.2011.01.065 | Serine/threonine-protein kinase mTOR | 1 |
| 21316229 | 10.1016/j.bmcl.2011.01.065 | Unchecked | 1 |
| 21316229 | 10.1016/j.bmcl.2011.01.065 | HCT-116 | 1 |
| 21316229 | 10.1016/j.bmcl.2011.01.065 | T47D | 1 |
| 21316229 | 10.1016/j.bmcl.2011.01.065 | PC-3 | 1 |
| 21316229 | 10.1016/j.bmcl.2011.01.065 | Liver microsomes | 1 |
Data from ChEMBL 36 via Core Engine